I’ve said it before but the AI industry looks a lot like biotech / biomanufacturing. Huge R&D budget to produce products that are ultimately highly complex commodities. CapEx-intensive to build new “manufacturing” capacity. COGS matters. Regulation / IP control will be needed to protect innovators.